Absorption |
Blood-Brain Barrier | BBB+ | 0.9692 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.8223 |
P-glycoprotein Substrate | Substrate | 0.7126 |
P-glycoprotein Inhibitor | Inhibitor | 0.7243 |
Non-inhibitor | 0.8906 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7693 |
Distribution |
Subcellular localization | Mitochondria | 0.8710 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8337 |
CYP450 2D6 Substrate | Non-substrate | 0.9327 |
CYP450 3A4 Substrate | Substrate | 0.7512 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9533 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9434 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9412 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7874 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8711 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9270 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9562 |
Non-inhibitor | 0.7248 |
AMES Toxicity | Non AMES toxic | 0.9182 |
Carcinogens | Non-carcinogens | 0.9568 |
Fish Toxicity | High FHMT | 0.9924 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9452 |
Honey Bee Toxicity | High HBT | 0.8027 |
Biodegradation | Not ready biodegradable | 0.9596 |
Acute Oral Toxicity | IV | 0.6859 |
Carcinogenicity (Three-class) | Non-required | 0.4722 |